Skip to main content
. 2022 Nov 8;13:874028. doi: 10.3389/fphar.2022.874028

FIGURE 1.

FIGURE 1

Disease-free survival (DFS) and progression-free survival (PFS) for the study groups (Placebo vs. PMA-ZEO).